Nine Vanderbilt technologies awarded U.S. patent protection in July

The month of July brought in U.S. patent protection for nine Vanderbilt University technologies, ranging in scope from mass spectrometry to drug development. The technologies earning patent protection are: 

 

8,790,650

 

Methods of using an antibody to inhibit WNT-mediated cardiac remodeling

 

8,784,698

 

Surface structures for enhancement of quantum yield in broad spectrum emission nanocrystals

 

8,779,157

 

MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

 

8,778,695

 

Methods and apparatuses for analyzing biological samples by mass spectrometry

 

8,772,509

 

Indole compounds as positive allosteric modulators of the muscarinic receptor

 

8,771,754

 

Use of GSK3 inhibitors in combination with radiation therapies

 

8,771,290

 

Microstereotactic table

 

8,768,022

 

Apparatus and methods of compensating for organ deformation, registration of internal structures to images, and applications of same

 

8,765,097

 

Ligands to radiation-induced molecules

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter